Recent reports have shown that inaccurate blood glucose testing meters being sold are leading to poor health care. Although diabetes can be very manageable, the accuracy of the glucose testing meters is vital. Not all products are the same - so much so that the range can give a false sense of sugar control OR a false need for insulin. The FDA held hearings this past March to consider the need for making these guidelines stricter, and Bionime presented data showing the need for stricter guidelines, as well as how Bionime itself is already able to meet hospital accuracy standards. Bionime is one of the few BGM products on the markets that exceeds the highest standard of accuracy and precision, with low lot to lot variances. This means that diabetics get the RIGHT information with every test, especially important in this economy where patients have to watch their spending closely.
Bionime offers a complete line of products to meet the specific needs of various diabetics-
GM 100
Smallest, sleekest
Requires no coding
Easy-to-read screen
One of the lowest CVs in the industry
Patented, large-sized rigid test stripes, adding to its ease of use and less waste
GM 550
Unique auto-code feature, provides for increased accuracy
Large, easy-to-read LCD screen
Backlit screen so one can read in low light
500 test memory
Patented, large-sized rigid test stripes, adding to its ease of use and less waste
About Bionime
Established in April 2003, BIONIME is specialized in the business of biotechnology and medical testing. The Rightest line of Blood Glucose Monitors (BGM) is our first product to be fully commercialized. BIONIME integrates top-tier expertise in medical science, chemistry, electronics and precision engineering to commercialize our patented noble metal, biosensor technology used in our meters and test strips. Today, BIONIME employs more than 500 people and operates 3 subsidiaries in Europe, the America’s and Asia. Our products have been shown to meet or exceed the highest standards of accuracy and precision in numerous studies published in leading international clinical journals. Bionime products are distributed worldwide and are available in all the major markets. Through our continued commitment to quality and with the continued support of customers worldwide, Bionime will continue to take the lead in providing the highest quality, most accurate and reliable products available in the BGM market.
About BionimeUSA
BionimeUSA Corporation, a wholly owned subsidiary of Bionime Corporation (Taiwan Stock Exchange – Emerging Markets 4737), is the North America and Latin America sales and marketing arm of Bionime Corporation. BionimeUSA was established in 2007 to provide distributors, retailers and consumers a direct, “locally” based company to handle sales, marketing, distribution, customer service and technical support. Bionime’s complete line of branded, co-branded and OEM BGM products are available through BionimeUSA. For more information regarding BionimeUSA Corporation or availability of our products, call 858-481-8485 or visit our Web Site at www.bionimeusa.com
